January 23, 2018 / 8:05 AM / 7 months ago

BRIEF-Sobi says FDA grants fast track status for SOBI003 drug candidate

Jan 23 (Reuters) - Swedish Orphan Biovitrum:

* FDA ACCEPTS INVESTIGATIONAL NEW DRUG APPLICATION AND GRANTS FAST TRACK STATUS FOR SOBI003 FOR THE TREATMENT OF MPS IIIA

* SAYS ‍CLINICAL STUDY WITH SOBI003 IS EXPECTED TO START DURING 2018​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below